Michael Thomas Brandl

1 Patent

• US123382492025

  Crystalline Forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n′-methoxyurea

  Takeda Pharmaceutical Company Limited

  0 cites